The Institute of Cancer Research, London, is one of the world’s most influential cancer research organisations. Today read about a new test that can predict breast cancer survival, our scientific discoveries and how you can study at the ICR.
Combining a new targeted drug that blocks one of cancer’s escape routes could boost the effectiveness of combined chemo-radiotherapy for head and neck cancers and stop cells becoming resistant to treatment.
Assessing the cell ‘ecosystems’ at sites where ovarian cancer has spread round the body strongly predicts the chances of surviving from the disease, a new study reports.
The ICR and The Royal Marsden have been awarded £43 million over five years by the National Institute for Health Research. The Biomedical Research Centre is the only BRC specifically focused on cancer.
To achieve our aims, we need to put down strong foundations in the way we organise and support our research.
We will take on the challenge of cancer’s complexity, evolution and drug resistance through the discovery of innovative new approaches to cancer treatment.
We will deliver better outcomes and improved quality of life for patients by establishing innovative treatments, diagnostics and strategies for prevention as part of routine healthcare.
We will move a step closer to cure by bringing personalised treatments into the clinic and developing them for patients.
We will overcome the challenges posed by cancer’s complexity, adaptability and evolution through scientific and clinical excellence, innovation and partnership.
We will comprehend the full complexity of cancer by harnessing the power of new technologies and Big Data.
We need your help to better understand how cancer develops when the complex process of cell division goes wrong.
Our Chief Executive and President, Professor Paul Workman, shares his experiences on his blog, The Drug Discoverer.
For more than 100 years, the ICR has played an important role in shaping understanding of cancer and how it can be treated.
See what life is like as a student at The Institute of Cancer Research, the UK’s leading academic research centre.
We work in close partnership with industry to take results into the clinic as soon as possible, and make sure our research delivers for cancer patients.
The ICR is the top-ranked academic research centre in the UK after coming first overall in the 2014 Research Excellence Framework.
#TrekFest 2016 is an ultimate UK endurance challenge - find out how you can take part to support the ICR's research: https://t.co/vjzP2rGRm5
Could a new class of cancer drugs light the way forward for treating leukaemia?
Discovering hope: the future of drug research for prostate cancer